Notepad
The notepad is empty.
The basket is empty.
Free shipping possible
Free shipping possible
Please wait - the print view of the page is being prepared.
The print dialogue opens as soon as the page has been completely loaded.
If the print preview is incomplete, please close it and select "Print again".
Transaction Cost Theories and Health Policies
ISBN/GTIN

Transaction Cost Theories and Health Policies

still a useful approach for liberal economies - Großformatiges Paperback. Klappenbroschur
PaperbackPaperback
EUR49,00

Product description

This book includes essays on Transaction Cost theories for Health policies; it shows that such an approach is still useful for liberal economies. It is part of a larger research agenda to develop policy aiding decision tools and address inefficiencies of medical markets. The Transaction Cost Economics framework is applied for a project on re-engineering of California primary care; then an emerging theoretical framework called the "3Ps" develops further a Transaction Cost Political theory with a business approach; it combines Politics, Patients and Products from companies for market access, with 3P from the demand side: Physicians, Pharmacists and Patients. These actors choose individual cost reduction strategies for patients, this explicit information complements the implicit cost cues used in the cost sensitivity simulators (Huttin-Endepusresearch, 2017). Then, the author uses this "3P" framework in two case studies: France and Germany. Results identified that physicians were key players in Germany versus pharmacists in France, with their choices of individual cost reduction strategies. The Transaction Cost approach remains useful for Random Utility Models in health insurance.
Read more

Details

ISBN/GTIN978-3-659-84416-4
Product TypePaperback
BindingPaperback
Publishing date25/01/2024
Pages64 pages
LanguageEnglish
Article no.28250917
CatalogsZeitfracht
Data source no.N3000002006064
Product groupBU780
More details

Ratings

Author

Prof Dr Christine Huttin created a scientific enterprise (R&D), partly from an evaluation network on Pharmaceutical Policies in Cambridge, Mass/USA for new metrics on economic topics, data analytics in health care & disease econometrics. She holds a BS, MBA (ESSEC), PhD (EHESS, Pol Econ-Bus), Harvard Takemi/95, emeritus prof at Aix- Marseille Univ.

More products from Huttin, Christine C.

Subjects